Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Pelletier

Showing results (301-310 of 314) with videos related to

Pageof 32
Sort By:
The Annals of Thoracic Surgery|June 5, 2001
Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesisM A Marchand, M R Aupart, R Norton, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 6, 2024
Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous Melanoma Mouse ModelKevinn Eddy, Kajal Gupta, Mohamad Naser Eddin, et al.
Bioorganic & Medicinal Chemistry|May 31, 2008
2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptorJeffrey C Pelletier, Murty Chengalvala, Josh Cottom, et al.
Environmental Toxicology and Chemistry|November 20, 2012
Use of a novel sediment exposure to determine the effects of triclosan on estuarine benthic communitiesKay T Ho, Anthony A Chariton, Lisa M Portis, et al.
JACC. Advances|September 23, 2022
Clinical Implementation of Combined Monogenic and Polygenic Risk Disclosure for Coronary Artery DiseaseDimitri J Maamari, Deanna G Brockman, Krishna Aragam, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2010
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptorMatthew D Vera, Joseph T Lundquist, Murty V Chengalvala, et al.
ACS Chemical Neuroscience|February 14, 2015
Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse modelsSaktimayee M Roy, Valerie L Grum-Tokars, James P Schavocky, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2021
Challenges and Errors in Genetic Testing: The Fifth Case SeriesMeagan B Farmer, Danielle C Bonadies, Holly J Pederson, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole templateDiane B Hauze, Murty V Chengalvala, Joshua E Cottom, et al.
Plos One|July 11, 2013
Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic DysfunctionD Martin Watterson, Valerie L Grum-Tokars, Saktimayee M Roy, et al.
Pageof 32

Showing results (301-310 of 314) with videos related to

Sort By:
Pageof 32
The Annals of Thoracic Surgery|June 5, 2001
Fifteen-year experience with the mitral Carpentier-Edwards PERIMOUNT pericardial bioprosthesisM A Marchand, M R Aupart, R Norton, et al.
JID Innovations : Skin Science From Molecules to Population Health|March 6, 2024
Assessing Longitudinal Treatment Efficacies and Alterations in Molecular Markers Associated with Glutamatergic Signaling and Immune Checkpoint Inhibitors in a Spontaneous Melanoma Mouse ModelKevinn Eddy, Kajal Gupta, Mohamad Naser Eddin, et al.
Bioorganic & Medicinal Chemistry|May 31, 2008
2-phenyl-4-piperazinylbenzimidazoles: orally active inhibitors of the gonadotropin releasing hormone (GnRH) receptorJeffrey C Pelletier, Murty Chengalvala, Josh Cottom, et al.
Environmental Toxicology and Chemistry|November 20, 2012
Use of a novel sediment exposure to determine the effects of triclosan on estuarine benthic communitiesKay T Ho, Anthony A Chariton, Lisa M Portis, et al.
JACC. Advances|September 23, 2022
Clinical Implementation of Combined Monogenic and Polygenic Risk Disclosure for Coronary Artery DiseaseDimitri J Maamari, Deanna G Brockman, Krishna Aragam, et al.
Bioorganic & Medicinal Chemistry Letters|March 19, 2010
Synthesis and biological evaluation of piperazinyl heterocyclic antagonists of the gonadotropin releasing hormone (GnRH) receptorMatthew D Vera, Joseph T Lundquist, Murty V Chengalvala, et al.
ACS Chemical Neuroscience|February 14, 2015
Targeting human central nervous system protein kinases: An isoform selective p38αMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse modelsSaktimayee M Roy, Valerie L Grum-Tokars, James P Schavocky, et al.
Cancer Journal (Sudbury, Mass.)|December 14, 2021
Challenges and Errors in Genetic Testing: The Fifth Case SeriesMeagan B Farmer, Danielle C Bonadies, Holly J Pederson, et al.
Bioorganic & Medicinal Chemistry Letters|March 3, 2009
Small molecule antagonists of the gonadotropin-releasing hormone (GnRH) receptor: structure-activity relationships of small heterocyclic groups appended to the 2-phenyl-4-piperazinyl-benzimidazole templateDiane B Hauze, Murty V Chengalvala, Joshua E Cottom, et al.
Plos One|July 11, 2013
Development of Novel In Vivo Chemical Probes to Address CNS Protein Kinase Involvement in Synaptic DysfunctionD Martin Watterson, Valerie L Grum-Tokars, Saktimayee M Roy, et al.
Pageof 32